News | May 20, 2015

Mirada Medical Highlights Deformable Image Registration at ESTRO 2015

Pair of studies examine role of advanced technique in radiotherapy planning

May 20, 2015 — State-of-the-art deformable image registration and multimodality imaging techniques continue to drive advances in radiation therapy clinical practice. Novel research into the utility and benefit of such advanced techniques are the topics that the Mirada Medical scientific team and collaborators presented at the 3rd ESTRO (European Society for Radiotherapy and Oncology) forum conference, April 24-28 in Barcelona, Spain.

The first study, entitled “The potential role of diagnostic position MRI with deformable registration for radiotherapy planning of HNSCC”, was in collaboration with Leeds St. James Hospital (U.K.). This study examined the use of magnetic resonance imaging (MRI) acquired in diagnostic position that are fused to the planning computed tomography (CT) using Mirada CT-MR Deformable Image Registration, and the consequent effects on contouring accuracy and intra-observer variability. Accurate target and organs-at-risk structures are a prerequisite for effective radiation treatment. The study compared a number of planning structures in head and neck squamous cell carcinoma patients drawn on the planning CT alone, diagnostic MRI alone and planning MRI alone. The results showed that the gross tumour volume (GTV) accuracy improved markedly when using the diagnostic MRI, and intra-observer variability reduced.

The second study, entitled “Fractionation-corrected doses with deformable registration as a tool for treatment plan comparison”, was in collaboration with Tampere University Hospital (Finland). It examines the role of Mirada CT-CT Deformable Image Registration in the task of decision-making for patients with recurrent disease. The study presents a framework for evaluating the dose to organs-at-risk when considering multiple treatments and compares the results when performing raw dose summation and biological dose summation — both with and without healing. Importantly, the critical step of registration quality assessment is discussed, requiring the assessment of both the image fusion and the deformation field to ensure biological plausibility.

For more information: www.mirada-medical.com

Related Content

Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
January 8, 2018 — EchoPixel showcased the latest version of True 3D, its interactive,...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
FDA Announces Final Guidance and Webinar for Technical Considerations for 3-D-Printed Medical Devices
News | 3-D Printing | January 03, 2018
The U.S. Food and Drug Administration (FDA) issued the final version of the guidance, “Technical Considerations for...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init